Polyplus now part of Sartorius

Polyplus Transfection is a leading biotechnology company that is revolutionizing gene delivery with innovative nucleic acid solutions for research, bioproduction, and therapeutics. Situated near the University of Strasbourg in Eastern France, the company has been a key player in the industry since its establishment in 2001.

With a strong focus on developing, marketing, and selling advanced solutions for the delivery of nucleic acids, Polyplus-transfection has gained recognition for its quality and innovation, holding ISO 9001 certification since 2002. The company's unique array of reagents for gene, oligonucleotide, and siRNA transfection is distributed globally through an extensive network.

Polyplus-transfection's contribution extends to clinical trials worldwide, where its reagents are increasingly utilized. Additionally, the company boasts an extensive portfolio of patents and licenses, including innovative methods for therapeutic siRNA delivery.

The company recently secured a significant €2.50M investment in a Venture Round on 11 January 2011, with backing from Crédit Mutuel Innovation, CIC Finance, and Sudinnova, underlining its appeal to investors in the biotechnology and healthcare industries.